New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity. 1977

I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh

UI MeSH Term Description Entries
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
June 1975, The New England journal of medicine,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
June 1988, Cancer,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
January 1978, Obstetrics and gynecology,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
September 1976, Obstetrics and gynecology,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
December 1979, Obstetrics and gynecology,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
December 1977, Cancer treatment reports,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
May 1985, American journal of obstetrics and gynecology,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
February 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
February 1980, Cancer,
I Djerassi, and J S Kim, and N Nayak, and H Ohanissian, and S Adler, and S Hsieh
September 1980, Harefuah,
Copied contents to your clipboard!